Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

L-Arginine is the substrate of endothelial nitric oxide synthase (eNOS) and the main precursor of nitric oxide (NO) in the vascular endothelium. L-Arginine improves endothelial function in patients with hypercholesterolemia, hypertension and smokers, while its role in diabetes remains unclear. Oral supplementation of L-arginine leads to a significant improvement of endothelium-dependent forearm vasodilation in hypercholesterolemic patients, while intravenous infusion of L-arginine improves endothelial function in healthy smokers. L-Arginine has anti-hypertensive properties, although its effects on endothelial function in hypertensive patients needs further evaluation. In conclusion, L-arginine administration may be useful in patients with premature atherosclerosis.

Original publication

DOI

10.1016/j.ijcard.2006.04.062

Type

Journal article

Journal

Int J Cardiol

Publication Date

04/04/2007

Volume

116

Pages

300 - 308

Keywords

Age Factors, Arginine, Atherosclerosis, Cardiovascular Agents, Diabetes Mellitus, Endothelium, Vascular, Female, Humans, Male, Nitric Oxide, Nitric Oxide Synthase Type III, Time Factors, Vasodilation